Add to ORKGRenal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosi
SIGLEAvailable from British Library Document Supply Centre-DSC:3578.772(77) / BLDSC - British Librar...
Thrombotic microangiopathy in a patient with Sezary syndrome treated with interferon
International audienceThrombotic microangiopathy is a rare but severe complication of treatment with...
We report the case of a 53-year-old woman treated for 8 years with Betaferon® (interferon-β-1b), who...
Renal thrombotic microangiopathy in patients with chronic myelogenous leukaemia treated with interfe...
microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia. Nephrology, ...
Background: Secondary thrombotic thrombocytopenic purpura (TTP) due to interferon beta-1a intramuscu...
Many drugs have been reported to cause thrombotic microangiopathy (TMA), yet evidence supporting a d...
Many drugs have been reported to cause thrombotic microangiopathy (TMA), yet evidence supporting a d...
Interferon (IFN) has been associated with development of thrombotic microangiopathy including thromb...
Recurrent nephrotic syndrome in patient with multiple sclerosis treated with interferon beta-1
none4noNo abstract avalilablemixedLa Manna, Gaetano; Baraldi, Olga; Corradetti, Valeria; Comai, Gior...
Abstract Background and aims Interferon beta (IFNβ) is a well‐established first‐line therapy for rel...
The chelator somatostatin analogue dota-D-phe(1)-tyr(3)-octreotide (DOTATOC), which is stably labele...
Interferon β-1a (IFNβ1a) is considered safe in relapsing-remitting multiple sclerosis (RRMS). Drug-i...
SIGLEAvailable from British Library Document Supply Centre-DSC:3578.772(77) / BLDSC - British Librar...
Thrombotic microangiopathy in a patient with Sezary syndrome treated with interferon
International audienceThrombotic microangiopathy is a rare but severe complication of treatment with...
We report the case of a 53-year-old woman treated for 8 years with Betaferon® (interferon-β-1b), who...
Renal thrombotic microangiopathy in patients with chronic myelogenous leukaemia treated with interfe...
microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia. Nephrology, ...
Background: Secondary thrombotic thrombocytopenic purpura (TTP) due to interferon beta-1a intramuscu...
Many drugs have been reported to cause thrombotic microangiopathy (TMA), yet evidence supporting a d...
Many drugs have been reported to cause thrombotic microangiopathy (TMA), yet evidence supporting a d...
Interferon (IFN) has been associated with development of thrombotic microangiopathy including thromb...
Recurrent nephrotic syndrome in patient with multiple sclerosis treated with interferon beta-1
none4noNo abstract avalilablemixedLa Manna, Gaetano; Baraldi, Olga; Corradetti, Valeria; Comai, Gior...
Abstract Background and aims Interferon beta (IFNβ) is a well‐established first‐line therapy for rel...
The chelator somatostatin analogue dota-D-phe(1)-tyr(3)-octreotide (DOTATOC), which is stably labele...
Interferon β-1a (IFNβ1a) is considered safe in relapsing-remitting multiple sclerosis (RRMS). Drug-i...
SIGLEAvailable from British Library Document Supply Centre-DSC:3578.772(77) / BLDSC - British Librar...
Thrombotic microangiopathy in a patient with Sezary syndrome treated with interferon
International audienceThrombotic microangiopathy is a rare but severe complication of treatment with...